GemPharmatech Co Ltd (688046)

Currency in CNY
31.39
-1.08(-3.33%)
Closed·
688046 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
31.0132.40
52 wk Range
12.8943.47
Key Statistics
Bid/Ask
31.36 / 31.39
Prev. Close
31.39
Open
31.67
Day's Range
31.01-32.4
52 wk Range
12.89-43.47
Volume
3.54M
Average Volume (3m)
10.99M
1-Year Change
70.7835%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
688046 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
39.32
Upside
+25.26%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 39.32
(+25.26% Upside)

Earnings

Latest Release
29/10/2026
EPS / Forecast
-- / --
Revenue / Forecast
264M / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.50
Dividend Yield
1.08%
Industry Median 1.13%
Annualised payout
0.35
Paid annually
5-Years Growth
-
Growth Streak

688046 Income Statement

Compare 688046 to Peers and Sector

Metrics to compare
688046
Peers
Sector
Relationship
P/E Ratio
63.3x55.9x−0.2x
PEG Ratio
0.980.400.00
Price/Book
5.5x4.1x2.6x
Price / LTM Sales
13.6x5.3x2.8x
Upside (Analyst Target)
25.3%24.3%65.0%
Fair Value Upside
Unlock0.9%9.5%Unlock

GemPharmatech Co., Ltd., a contract research organization, provides genetically engineered mouse models and preclinical research services to the scientific community worldwide. The company offers mouse models, including knockout and conditional knockout mouse, knock-in mouse, point-mutation mouse, transgenic mouse, immunodeficient mouse, germ-free mouse, and tool mice models, as well as operates wild mouse project. It also provides custom model generation, preclinical testing, germ-free and microbiome, cell lines and customization, custom breeding, animal quality testing, and other services. The company has a strategic alliance with Memorial Sloan Kettering Cancer Center (MSK) to accelerate the discovery of new therapeutic antibodies. The company was founded in 2017 and is headquartered in Nanjing, China.

Employees
1590
Market
China

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
78.53M19.19%2.55B
Other Institutional Investors
230.77M56.40%7.49B
Public Companies & Retail Investors
99.85M24.40%3.24B
Total
409.16M100.00%13.29B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Nanjing Laoyan Venture Capital Partnership Enterprise (Limited Partnership)47.98%196,317,1856,374,419
Zhong Ou Fund Management Co., Ltd4.60%18,818,260611,029

FAQ

What Is the GemPharmatech (688046) Stock Price Today?

The GemPharmatech stock price today is 31.39 CNY.

What Stock Exchange Does GemPharmatech Trade On?

GemPharmatech is listed and trades on the Shanghai Stock Exchange.

What Is the Stock Symbol for GemPharmatech?

The stock symbol for GemPharmatech is "688046."

Does GemPharmatech Pay Dividends? What’s The Current Dividend Yield?

The GemPharmatech dividend yield is 1.1%%.

What Is the GemPharmatech Market Cap?

As of today, GemPharmatech market cap is 12.84B CNY.

What Is GemPharmatech's Earnings Per Share (TTM)?

The GemPharmatech EPS (TTM) is 0.50.

From a Technical Analysis Perspective, Is 688046 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has GemPharmatech Stock Split?

GemPharmatech has split 0 times.

How Many Employees Does GemPharmatech Have?

GemPharmatech has 1590 employees.

What is the current trading status of GemPharmatech (688046)?

As of 16/11/2026, GemPharmatech (688046) is trading at a price of 31.39 CNY, with a previous close of 31.39 CNY. The stock has fluctuated within a day range of 31.01 CNY to 32.40 CNY, while its 52-week range spans from 12.89 CNY to 43.47 CNY.

What Is GemPharmatech (688046) Price Target According to Analysts?

The average 12-month price target for GemPharmatech is 39.32 CNY, with a high estimate of 39.32 CNY and a low estimate of 39.32 CNY. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +25.26% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.